Additional effects of moderate-dose fluticasone and salmeterol combination therapy on exacerbations and airflow limitations in patients with COPD in Japa
Not Applicable
- Conditions
- COPD
- Registration Number
- JPRN-UMIN000003403
- Lead Sponsor
- Kyusyu Asthma & COPD Forum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1008
Inclusion Criteria
Not provided
Exclusion Criteria
1. other respiratory diseases 2. regular use of inhaled corticosteroids 3. regular use of inhaled and transdermal beta2 agonists 4. severe other orgen diseases 5. active malignancies
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Prevent the numbers and severity of exacerbation/yr/patient
- Secondary Outcome Measures
Name Time Method Prevent the decline of FEV1